Related Experiment Video

Updated: Jun 29, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

959

Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer

Hua Su1, Chao Peng1, Yang Liu2

  • 1Xingyi People's Hospital, Xinyi, China.

Frontiers in Cell and Developmental Biology
|April 2, 2024
PubMed

Insights

Targeting the PI3K/Akt pathway may enhance cancer cell death via ferroptosis. This approach offers a novel strategy to overcome drug resistance and improve cancer treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Mechanisms

Background:

  • Cancer presents a significant global health challenge, necessitating novel therapeutic strategies.
  • The Phosphatidylinositol 3-kinase/Protein kinase B (PI3K/Akt) signaling pathway is frequently dysregulated in cancers, driving proliferation and therapy resistance.
  • Ferroptosis, a distinct form of regulated cell death, involves iron-dependent lipid peroxidation and is implicated in cancer progression.

Purpose of the Study:

  • To explore the intricate relationship between the dysregulated PI3K/Akt pathway and ferroptosis in cancer.
  • To investigate the potential of targeting the PI3K/Akt pathway to induce or enhance ferroptosis.
  • To identify new therapeutic avenues for overcoming cancer drug resistance.

Main Methods:

  • Comprehensive literature review of studies investigating the PI3K/Akt pathway and ferroptosis.
  • Analysis of molecular mechanisms linking PI3K/Akt signaling to ferroptosis regulation.
  • Evaluation of preclinical evidence for PI3K/Akt inhibition in sensitizing cancer cells to ferroptosis.

Main Results:

  • Dysregulation of the PI3K/Akt pathway is a key driver in cancer initiation, progression, and therapeutic resistance.
  • Evidence suggests that inhibiting the PI3K/Akt pathway can sensitize cancer cells to ferroptosis.
  • This interplay offers insights into novel strategies for cancer cell death induction.

Conclusions:

  • Disrupting the PI3K/Akt pathway represents a promising strategy to enhance ferroptosis in cancer cells.
  • This approach holds potential for overcoming acquired drug resistance.
  • Targeting the PI3K/Akt/ferroptosis axis could lead to improved cancer treatment outcomes.
Keywords:
AktPI3KPI3K/AKTcancercell deathferroptosis

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.5K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

902

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K